1	have be treat with felbamate or vigabatrin within the 6 month prior to screening if a subject have be previously treat with vigabatrin 6 month prior to screening a visual perimetry test perform within 6 month prior to screening must show normal visual field or no worsening of recognized visual field|felbamate[19,28]|||||||||C0060135|24812|24812|felbamate
1	have be treat with felbamate or vigabatrin within the 6 month prior to screening if a subject have be previously treat with vigabatrin 6 month prior to screening a visual perimetry test perform within 6 month prior to screening must show normal visual field or no worsening of recognized visual field|vigabatrin[32,42]|||||||6 month[54,61]||C0048044|14851|14851|vigabatrin
1	have be treat with felbamate or vigabatrin within the 6 month prior to screening if a subject have be previously treat with vigabatrin 6 month prior to screening a visual perimetry test perform within 6 month prior to screening must show normal visual field or no worsening of recognized visual field|vigabatrin[124,134]|||||||6 month[135,142]||C0048044|14851|14851|vigabatrin
2	abnormality a compare with prior to vigabatrin treatment|vigabatrin[337,347]|||||||||C0048044|14851|14851|vigabatrin
